Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO20553 | Zingiber officinale | Species | Zingiberaceae | Eukaryota | TM-MC* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT546 | Individual Protein | Retinoid X receptor alpha | Homo sapiens | Potency | 28183.8 | nM | PubChem BioAssay data set | |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 4.5 | nM | PubChem BioAssay data set | |
NPT540 | Individual Protein | Bile acid receptor FXR | Homo sapiens | Potency | 39810.7 | nM | PubChem BioAssay data set | |
NPT158 | Individual Protein | Nuclear receptor subfamily 1 group I member 2 | Rattus norvegicus | Potency | 39810.7 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 44668.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 76958.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 54482.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 30637.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 68589.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 61130.6 | nM | PubChem BioAssay data set | ||
NPT163 | Individual Protein | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens | Potency | 34665.4 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 61644.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 21872.4 | nM | PubChem BioAssay data set | ||
NPT603 | Individual Protein | Olfactory receptor 5K1 | Homo sapiens | Inhibition | >= | 40 | % | Patent: WO2013171535 A3 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC2982 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.6462 | Remote Similarity | NPC172170 |
0.6357 | Remote Similarity | NPC39818 |
0.6299 | Remote Similarity | NPC323726 |
0.6259 | Remote Similarity | NPC226143 |
0.6259 | Remote Similarity | NPC130655 |
0.6194 | Remote Similarity | NPC470579 |
0.6164 | Remote Similarity | NPC280807 |
0.6164 | Remote Similarity | NPC314431 |
0.6122 | Remote Similarity | NPC316746 |
0.6093 | Remote Similarity | NPC159722 |
0.608 | Remote Similarity | NPC323420 |
0.6069 | Remote Similarity | NPC314278 |
0.6028 | Remote Similarity | NPC177684 |
0.6028 | Remote Similarity | NPC291962 |
0.6016 | Remote Similarity | NPC239185 |
0.6016 | Remote Similarity | NPC265220 |
0.6 | Remote Similarity | NPC472244 |
0.6 | Remote Similarity | NPC133461 |
0.6 | Remote Similarity | NPC470343 |
0.5986 | Remote Similarity | NPC258531 |
0.5986 | Remote Similarity | NPC161956 |
0.5986 | Remote Similarity | NPC279385 |
0.5986 | Remote Similarity | NPC112373 |
0.5986 | Remote Similarity | NPC150863 |
0.5986 | Remote Similarity | NPC179605 |
0.5984 | Remote Similarity | NPC160339 |
0.5984 | Remote Similarity | NPC307 |
0.5969 | Remote Similarity | NPC134882 |
0.5969 | Remote Similarity | NPC75724 |
0.5962 | Remote Similarity | NPC190945 |
0.5952 | Remote Similarity | NPC153885 |
0.5952 | Remote Similarity | NPC59677 |
0.5952 | Remote Similarity | NPC155232 |
0.5946 | Remote Similarity | NPC472245 |
0.5944 | Remote Similarity | NPC103292 |
0.5938 | Remote Similarity | NPC40209 |
0.5938 | Remote Similarity | NPC185208 |
0.5938 | Remote Similarity | NPC219573 |
0.592 | Remote Similarity | NPC173413 |
0.5906 | Remote Similarity | NPC238219 |
0.5878 | Remote Similarity | NPC109514 |
0.5878 | Remote Similarity | NPC476993 |
0.5865 | Remote Similarity | NPC38262 |
0.586 | Remote Similarity | NPC282578 |
0.5859 | Remote Similarity | NPC260233 |
0.5833 | Remote Similarity | NPC257490 |
0.5827 | Remote Similarity | NPC57051 |
0.5824 | Remote Similarity | NPC470023 |
0.5822 | Remote Similarity | NPC192533 |
0.58 | Remote Similarity | NPC314473 |
0.5794 | Remote Similarity | NPC277277 |
0.5793 | Remote Similarity | NPC268534 |
0.5792 | Remote Similarity | NPC470021 |
0.5782 | Remote Similarity | NPC474926 |
0.5781 | Remote Similarity | NPC289883 |
0.576 | Remote Similarity | NPC157778 |
0.5753 | Remote Similarity | NPC254698 |
0.5748 | Remote Similarity | NPC284475 |
0.5742 | Remote Similarity | NPC83214 |
0.5742 | Remote Similarity | NPC315224 |
0.5726 | Remote Similarity | NPC164526 |
0.5725 | Remote Similarity | NPC49994 |
0.5723 | Remote Similarity | NPC472242 |
0.5705 | Remote Similarity | NPC58827 |
0.5705 | Remote Similarity | NPC307437 |
0.5705 | Remote Similarity | NPC72473 |
0.5705 | Remote Similarity | NPC315051 |
0.5703 | Remote Similarity | NPC188844 |
0.5703 | Remote Similarity | NPC1682 |
0.5693 | Remote Similarity | NPC470252 |
0.568 | Remote Similarity | NPC71132 |
0.568 | Remote Similarity | NPC43945 |
0.5676 | Remote Similarity | NPC79698 |
0.5667 | Remote Similarity | NPC209389 |
0.5658 | Remote Similarity | NPC473962 |
0.5636 | Remote Similarity | NPC114808 |
0.5635 | Remote Similarity | NPC30445 |
0.5635 | Remote Similarity | NPC153308 |
0.5635 | Remote Similarity | NPC111233 |
0.5629 | Remote Similarity | NPC187231 |
0.5629 | Remote Similarity | NPC477432 |
0.5621 | Remote Similarity | NPC328270 |
0.562 | Remote Similarity | NPC112903 |
0.5605 | Remote Similarity | NPC472243 |
0.5602 | Remote Similarity | NPC36836 |
0.5602 | Remote Similarity | NPC63370 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC2982 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.705 | Intermediate Similarity | NPD1190 | Approved |
0.6846 | Remote Similarity | NPD1956 | Clinical (unspecified phase) |
0.6761 | Remote Similarity | NPD9471 | Clinical (unspecified phase) |
0.6597 | Remote Similarity | NPD1874 | Clinical (unspecified phase) |
0.6474 | Remote Similarity | NPD2790 | Discontinued |
0.6351 | Remote Similarity | NPD5227 | Clinical (unspecified phase) |
0.6268 | Remote Similarity | NPD660 | Approved |
0.6268 | Remote Similarity | NPD661 | Approved |
0.6268 | Remote Similarity | NPD657 | Approved |
0.6268 | Remote Similarity | NPD655 | Approved |
0.6267 | Remote Similarity | NPD7142 | Discontinued |
0.6205 | Remote Similarity | NPD7663 | Clinical (unspecified phase) |
0.6184 | Remote Similarity | NPD2010 | Phase 3 |
0.6164 | Remote Similarity | NPD2918 | Clinical (unspecified phase) |
0.6164 | Remote Similarity | NPD2919 | Clinical (unspecified phase) |
0.6154 | Remote Similarity | NPD1640 | Clinical (unspecified phase) |
0.6122 | Remote Similarity | NPD2754 | Discontinued |
0.6111 | Remote Similarity | NPD1574 | Approved |
0.6081 | Remote Similarity | NPD3502 | Discovery |
0.6069 | Remote Similarity | NPD1593 | Approved |
0.6069 | Remote Similarity | NPD797 | Clinical (unspecified phase) |
0.6039 | Remote Similarity | NPD2923 | Approved |
0.6027 | Remote Similarity | NPD701 | Approved |
0.6027 | Remote Similarity | NPD698 | Approved |
0.6016 | Remote Similarity | NPD3495 | Discontinued |
0.6013 | Remote Similarity | NPD5068 | Clinical (unspecified phase) |
0.6 | Remote Similarity | NPD997 | Clinical (unspecified phase) |
0.5987 | Remote Similarity | NPD4607 | Approved |
0.5987 | Remote Similarity | NPD6416 | Phase 2 |
0.5987 | Remote Similarity | NPD6342 | Discontinued |
0.5986 | Remote Similarity | NPD662 | Approved |
0.5986 | Remote Similarity | NPD658 | Approved |
0.5986 | Remote Similarity | NPD663 | Approved |
0.5986 | Remote Similarity | NPD659 | Approved |
0.5986 | Remote Similarity | NPD656 | Approved |
0.5962 | Remote Similarity | NPD2435 | Approved |
0.596 | Remote Similarity | NPD1410 | Phase 1 |
0.5949 | Remote Similarity | NPD3352 | Approved |
0.5948 | Remote Similarity | NPD6655 | Clinical (unspecified phase) |
0.5924 | Remote Similarity | NPD6185 | Discontinued |
0.5915 | Remote Similarity | NPD4335 | Clinical (unspecified phase) |
0.5901 | Remote Similarity | NPD3399 | Approved |
0.5887 | Remote Similarity | NPD457 | Approved |
0.5886 | Remote Similarity | NPD4041 | Approved |
0.5875 | Remote Similarity | NPD4513 | Discontinued |
0.5864 | Remote Similarity | NPD5086 | Approved |
0.586 | Remote Similarity | NPD5918 | Discontinued |
0.5849 | Remote Similarity | NPD6758 | Approved |
0.5845 | Remote Similarity | NPD1668 | Clinical (unspecified phase) |
0.5844 | Remote Similarity | NPD4167 | Phase 3 |
0.5833 | Remote Similarity | NPD6768 | Approved |
0.5833 | Remote Similarity | NPD1079 | Discontinued |
0.5833 | Remote Similarity | NPD6566 | Discontinued |
0.5827 | Remote Similarity | NPD456 | Approved |
0.5823 | Remote Similarity | NPD5932 | Phase 3 |
0.5823 | Remote Similarity | NPD5933 | Phase 3 |
0.5823 | Remote Similarity | NPD5931 | Phase 3 |
0.5809 | Remote Similarity | NPD476 | Approved |
0.5789 | Remote Similarity | NPD1531 | Approved |
0.5782 | Remote Similarity | NPD1036 | Approved |
0.5769 | Remote Similarity | NPD4461 | Discontinued |
0.5748 | Remote Similarity | NPD7609 | Phase 3 |
0.5742 | Remote Similarity | NPD12 | Approved |
0.5742 | Remote Similarity | NPD700 | Approved |
0.5742 | Remote Similarity | NPD13 | Approved |
0.5742 | Remote Similarity | NPD699 | Approved |
0.5742 | Remote Similarity | NPD697 | Approved |
0.5741 | Remote Similarity | NPD7670 | Clinical (unspecified phase) |
0.5724 | Remote Similarity | NPD1124 | Approved |
0.5724 | Remote Similarity | NPD1123 | Approved |
0.5724 | Remote Similarity | NPD1541 | Approved |
0.5714 | Remote Similarity | NPD1680 | Approved |
0.5714 | Remote Similarity | NPD1681 | Approved |
0.5714 | Remote Similarity | NPD1682 | Approved |
0.5706 | Remote Similarity | NPD2948 | Discontinued |
0.5703 | Remote Similarity | NPD7631 | Approved |
0.5696 | Remote Similarity | NPD7082 | Approved |
0.5695 | Remote Similarity | NPD486 | Clinical (unspecified phase) |
0.568 | Remote Similarity | NPD3252 | Approved |
0.568 | Remote Similarity | NPD650 | Approved |
0.5677 | Remote Similarity | NPD1532 | Approved |
0.5673 | Remote Similarity | NPD7795 | Phase 2 |
0.5669 | Remote Similarity | NPD1953 | Discontinued |
0.566 | Remote Similarity | NPD7259 | Approved |
0.566 | Remote Similarity | NPD7487 | Discontinued |
0.5655 | Remote Similarity | NPD1525 | Approved |
0.5652 | Remote Similarity | NPD7478 | Approved |
0.5652 | Remote Similarity | NPD7088 | Discontinued |
0.5647 | Remote Similarity | NPD710 | Clinical (unspecified phase) |
0.5643 | Remote Similarity | NPD181 | Approved |
0.5641 | Remote Similarity | NPD1626 | Approved |
0.564 | Remote Similarity | NPD7687 | Clinical (unspecified phase) |
0.5633 | Remote Similarity | NPD6414 | Clinical (unspecified phase) |
0.5632 | Remote Similarity | NPD3978 | Clinical (unspecified phase) |
0.5629 | Remote Similarity | NPD7114 | Clinical (unspecified phase) |
0.5625 | Remote Similarity | NPD7295 | Approved |
0.5621 | Remote Similarity | NPD6740 | Clinical (unspecified phase) |
0.5618 | Remote Similarity | NPD9468 | Clinical (unspecified phase) |
0.5616 | Remote Similarity | NPD9692 | Approved |
0.5616 | Remote Similarity | NPD9693 | Approved |
0.5608 | Remote Similarity | NPD182 | Clinical (unspecified phase) |
0.5607 | Remote Similarity | NPD3377 | Discontinued |
0.5604 | Remote Similarity | NPD5504 | Discontinued |
0.5603 | Remote Similarity | NPD731 | Approved |
0.5603 | Remote Similarity | NPD23 | Approved |
0.5603 | Remote Similarity | NPD14 | Approved |
0.5602 | Remote Similarity | NPD6571 | Approved |
0.5602 | Remote Similarity | NPD6855 | Clinical (unspecified phase) |
0.5602 | Remote Similarity | NPD6570 | Approved |
0.56 | Remote Similarity | NPD1560 | Clinical (unspecified phase) |
0.56 | Remote Similarity | NPD1221 | Approved |
0.56 | Remote Similarity | NPD2753 | Discontinued |
PubChem CID   | 6669 |
ChEMBL   | CHEMBL1877463 |
ZINC   |
Molecular Weight:   | 294.12 |
ALogP:   | 3.9065 |
MLogP:   | 2.23 |
XLogP:   | 4.091 |
# Rotatable Bonds:   | 12 |
Polar Surface Area:   | 103.35 |
# H-Bond Aceptor:   | 1 |
# H-Bond Donor:   | 0 |
# Rings:   | 1 |
# Heavy Atoms:   | 21 |